X0306
4
2019-12-02
0
0001649904
RHYTHM PHARMACEUTICALS, INC.
RYTM
0001473930
Foley Todd
C/O MPM ASSET MANAGEMENT
450 KENDALL STREET
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2019-12-02
4
S
0
25366
22.03
D
2491670
I
See Footnote
Common Stock
2019-12-03
4
S
0
16777
22.33
D
2474893
I
See Footnote
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The shares were sold as follows: 24,417 by MPM BioVentures V, L.P. ("BV V") and 949 by MPM Asset Management Investors BV5 LLC ("AM BV5"). MPM BioVentures V GP LLC and MPM BioVentures V LLC ("BV LLC") are the direct and indirect general partners of BV V and BV LLC is the manager of AM BV5. Ansbert Gadicke, Luke Evnin and Todd Foley are the members of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $21.63 to $22.42. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Shares are held as follows: 2,398,494 by BV V and 93,176 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Shares were sold as follows: 16,151 by BV V and 626 by AM BV5.
Shares are held as follows: 2,382,343 by BV V and 92,550 by AM BV5. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
/s/ Todd Foley
2019-12-03